{
  "docId": "019dd923-622c-750b-8b9a-3bcd52c6e583",
  "docSlug": "f06b0b5d2079",
  "documentTitle": "Soleno Therapeutics (SLNO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 81,
  "pageCount": 415,
  "prevPage": 80,
  "nextPage": 82,
  "slideType": "nominee_bio",
  "function": "introduce_nominees",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The slide captures qualitative feedback from a medical expert, highlighting low adoption rates and negative sentiment toward the company's sales approach.",
  "elementsJson": [
    "headline_text",
    "bullet_list",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-3bcd52c6e583/81",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583#slide-81",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Indicated extreme skepticism of Vykat, stating that all 8 colleagues met with the Soleno rep a few weeks ago, with only one start form submitted between them across 50 patients, which hasn't gotten insurance approval.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b29b-f5be6adb99f4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.86,
        "x": 0.07,
        "y": 0.24
      },
      "kind": "list",
      "text": "Indicated extreme skepticism of Vykat, stating that all 8 colleagues met with the Soleno rep a few weeks ago, with only one start form submitted between them across 50 patients, which hasn't gotten insurance approval.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8ca332c9-5219-4967-aa9f-ffe79f3db31e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.86,
        "x": 0.07,
        "y": 0.52
      },
      "kind": "list",
      "text": "Stated that the eight endocrinology colleagues at the recent Soleno presentation “are all well-trained” and that it was telling that only 1 out of 8 was willing to try Vykat in a single patient. The physician implied the Soleno presentation was “manipulative and questioned if it was “ethical” as it “overemphasized the horror stories” that is not representative of the hyperphagia of most PWS patients.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d1974386-3f5c-443f-ad8b-4256f688592c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.86,
        "x": 0.07,
        "y": 0.38
      },
      "kind": "list",
      "text": "Indicated no plans to submit any start forms for Vykat and that the only interest is driven by desperate PWS families active on social media and within the Jennifer Miller “cult” who may be pushing some physicians.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "de3a52a3-de87-4183-a37a-2f7966bd7fba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“It wasn't me; it was one of my colleagues....we know how this goes...when newer things come out...then if there's a lot of hurdles for insurance and things like that, then people become less enthusiastic.” — Endocrinologist #4",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b29b-f845812fa96a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "567847f9-9afc-4502-8bc0-97bcc3d453cd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "Endocrinologist #4: Academic center with 8 endocrinologists who manage ~50 PWS patients; personally manages 5 patients, and indicated a significant number of his colleagues trained at CHOP and are thus highly experienced with diazoxide, as CHOP is the leading user for hyperinsulinism – “four of us that trained at CHOP and diazoxide.”",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a984ceff-9c62-4459-8714-1a08f7316abb",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}